North China Pharmaceutical Company.Ltd (SHA:600812)
China · Delayed Price · Currency is CNY 4.830
-0.130 (-2.62%)
May 20, 2026, 11:29 AM CST
SHA:600812 Revenue
North China Pharmaceutical Company.Ltd had revenue of 2.15B CNY in the quarter ending March 31, 2026, a decrease of -16.36%. This brings the company's revenue in the last twelve months to 8.82B, down -10.78% year-over-year. In the year 2025, North China Pharmaceutical Company.Ltd had annual revenue of 9.24B, down -6.36%.
Revenue (ttm)
8.82B
Revenue Growth
-10.78%
P/S Ratio
0.96
Revenue / Employee
884.53K
Employees
9,972
Market Cap
8.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.24B | -627.92M | -6.36% |
| Dec 31, 2024 | 9.87B | -250.63M | -2.48% |
| Dec 31, 2023 | 10.12B | -379.75M | -3.62% |
| Dec 31, 2022 | 10.50B | 115.37M | 1.11% |
| Dec 31, 2021 | 10.38B | -1.11B | -9.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition